Organization · Venture Capital
Clay Capital fka VisVires New Protein
Clay Capital is a venture capital firm based in London that invests in agrifood technology companies across Europe and Asia. The firm focuses on innovative solutions that enhance the relationship between human health and the health of the planet.
Overview
What Clay Capital fka VisVires New Protein does
What Clay Capital fka VisVires New Protein is
Clay Capital is a venture capital firm based in London that invests in agrifood technology companies across Europe and Asia. The firm focuses on innovative solutions that enhance the relationship between human health and the health of the planet.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 27, 2026
Official channels
Find Clay Capital fka VisVires New Protein elsewhere
Open the official website or a supported primary organization account.
Capability profile
Clay Capital fka VisVires New Protein as a funder
Investment thesis
Clay Capital aims to reconnect human health and planetary health through innovative agrifood technology solutions.
Focus narrative
Clay Capital invests in Seed to Series C companies in the agrifood tech sector, addressing the interconnected challenges of environmental degradation, societal inequity, and human health. The firm seeks to promote sustainable, nutritious, and circular outcomes in food production and consumption, with a focus on innovative technologies that enhance food systems.
Value beyond capital
Clay Capital adds value to its portfolio companies through strategic guidance and operational expertise, leveraging the team's extensive experience in the agrifood sector. The firm emphasizes a collaborative approach, helping startups navigate challenges and scale their innovations effectively.
Portfolio and track record
- Recorded portfolio count
- 13
Portfolio context
Notable portfolio companies include: Abolis Biotechnologies: Develops scalable chemicals from microbes instead of petrochemicals. Aleph Farms: Produces beef without the need for cows. Collectiv Food: Reshapes urban food service supply chains. Cook-e: Provides robots that serve hot, healthy meals 24/7. Eratani: Digitizes rice farming from seed to sale. Infinite Roots: Unlocks the potential of mycelium for food. In Ovo: Addresses issues in egg production through sorting technology. MiAlgae: Converts whisky waste into sustainable omega-3. Mitte: Offers mineralized water on demand without plastic bottles. Nuritas: Harnesses the power of peptides from nature. Nutrition Innovation: Reimagines sugar to create healthier alternatives. NxtFood: Produces plant-based protein alternatives. Rootwave: Develops technology to eliminate weeds without chemicals.
Capability profile
Clay Capital fka VisVires New Protein as a publisher
Editorial focus
Clay Capital, formerly VisVires New Protein, focuses on deploying venture capital into high-impact agrifood technology. The organization supports teams that aim to improve the connection between human health and planetary health through innovative solutions. It invests in Seed to Series C companies primarily in the agrifood tech sector across Europe and Asia, addressing challenges related to environmental degradation, societal inequity, and human health.
Audience value
Clay Capital provides value by investing in innovative agrifood technologies that promote sustainable and nutritious food production, addressing critical global challenges in health and the environment.
Format and cadence
- Content formats
- blog
- Primary platform
- Website
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors · Founders
Flagship work and coverage
Flagship properties
Clay Capital's notable portfolio includes companies like Abolis Biotechnologies, Aleph Farms, and Cook-e, which are pioneering advancements in sustainable food production and technology.
Notable coverage
Clay Capital has been featured in various publications, highlighting its strategic investments and mission-driven approach to reconnecting human health and planetary health through food technology.
Common questions
What to know about Clay Capital fka VisVires New Protein
Upseed classifies Clay Capital fka VisVires New Protein under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.